MARY CVITKOVIC: Open Payments
NPI 1669134136 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 7 payments from 5 companies in 2025. Trend: 2023 $102 · 2024 $47 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 1 | $110 |
| Genentech USA, Inc. | 3 | $63 |
| Genmab U.S., Inc. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Orserdu, Itovebi, RYBREVANT, KEYTRUDA QLEX.
Industry payments across OH — which companies pay providers there.
